These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22987791)
1. Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents. Pieroni M; Girmay S; Sun D; Sahu R; Tekwani BL; Tan GT ChemMedChem; 2012 Nov; 7(11):1895-900. PubMed ID: 22987791 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of chalcones as potential antileishmanial agents. Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 4-chloro-3, 5-dinitrobenzotrifluoride analogues as antileishmanial agents. Pitzer KK; Werbovetz KA; Brendle JJ; Scovill JP J Med Chem; 1998 Nov; 41(24):4885-9. PubMed ID: 9822557 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis. Ortalli M; Varani S; Rosso C; Quintavalla A; Lombardo M; Trombini C Eur J Med Chem; 2019 May; 170():126-140. PubMed ID: 30878827 [TBL] [Abstract][Full Text] [Related]
5. 3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids. Kapou A; Benetis NP; Avlonitis N; Calogeropoulou T; Koufaki M; Scoulica E; Nikolaropoulos SS; Mavromoustakos T Bioorg Med Chem; 2007 Feb; 15(3):1252-65. PubMed ID: 17158053 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities. Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702 [TBL] [Abstract][Full Text] [Related]
8. Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines. Van Horn KS; Zhu X; Pandharkar T; Yang S; Vesely B; Vanaerschot M; Dujardin JC; Rijal S; Kyle DE; Wang MZ; Werbovetz KA; Manetsch R J Med Chem; 2014 Jun; 57(12):5141-56. PubMed ID: 24874647 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents. Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of 7-arylbenzo[c]acridine-5,6- diones as Potential Anti-Leishmanial and anti-trypanosomal Agents. Mahajan S; Khan SI; Tekwani BL; Khan IA; Singh IP Med Chem; 2018; 14(6):563-572. PubMed ID: 29485004 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives. Calogeropoulou T; Angelou P; Detsi A; Fragiadaki I; Scoulica E J Med Chem; 2008 Feb; 51(4):897-908. PubMed ID: 18220332 [TBL] [Abstract][Full Text] [Related]
13. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani. Wert L; Alakurtti S; Corral MJ; Sánchez-Fortún S; Yli-Kauhaluoma J; Alunda JM J Antibiot (Tokyo); 2011 Jul; 64(7):475-81. PubMed ID: 21522160 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of polyalthic acid derivatives for the treatment of neglected diseases. Mizuno CS; Souza AB; Tekwani BL; Ambrósio SR; Veneziani RC Bioorg Med Chem Lett; 2015 Dec; 25(23):5529-31. PubMed ID: 26520665 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines. Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054 [TBL] [Abstract][Full Text] [Related]
16. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line. Jain SK; Sahu R; Walker LA; Tekwani BL J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097 [TBL] [Abstract][Full Text] [Related]
18. Identification of new antileishmanial leads from hits obtained by high-throughput screening. Zhu X; Pandharkar T; Werbovetz K Antimicrob Agents Chemother; 2012 Mar; 56(3):1182-9. PubMed ID: 22143523 [TBL] [Abstract][Full Text] [Related]
19. Activity of and initial mechanistic studies on a novel antileishmanial agent identified through in silico pharmacophore development and database searching. Delfín DA; Bhattacharjee AK; Yakovich AJ; Werbovetz KA J Med Chem; 2006 Jul; 49(14):4196-207. PubMed ID: 16821779 [TBL] [Abstract][Full Text] [Related]
20. Leishmanicidal activity of two naphthoquinones against Leishmania donovani. Lezama-Dávila CM; Isaac-Márquez AP; Kapadia G; Owens K; Oghumu S; Beverley S; Satoskar AR Biol Pharm Bull; 2012; 35(10):1761-4. PubMed ID: 23037165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]